Gilead Sciences | Gilead Sciences | False Claims Act and related | 2013 | LA-AG | $250,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2003 | MULTI-AG | $40,000,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2005 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,000,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2006 | GA-AG | $418,952 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2012 | ID-AG | $2,600,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2011 | KS-AG | $4,250,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2012 | LA-AG | $10,000,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Glenmark Generics Inc. | Glenmark Pharmaceuticals | False Claims Act and related | 2015 | TX-AG | $13,750,000 |
Immunex Corp. | Amgen | False Claims Act and related | 2009 | IA-AG | $357,000 |
IVAX Pharmaceuticals | Teva Pharmaceutical Industries | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $5,400,000 |
Janssen Pharmaceutical Products, LP, Centocor, Inc., McNeil Pharmaceutical, Inc., Ortho Biotech Products, LP and Ortho-McNeil Pharmaceutical, Inc. | Johnson & Johnson | False Claims Act and related | 2012 | KY-AG | $7,000,000 |
Johnson & Johnson | Johnson & Johnson | False Claims Act and related | 2013 | LA-AG | $10,000,000 |
Johnson & Johnson et al. | Johnson & Johnson | False Claims Act and related | 2010 | HI-AG | $5,200,000 |
Johnson & Johnson | Johnson & Johnson | False Claims Act and related | 2011 | ID-AG | $2,000,000 |
King Pharmaceuticals | Pfizer | False Claims Act and related | 2006 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $124,000,000 |
Lupin Pharmaceuticals | Lupin Limited | False Claims Act and related | 2013 | LA-AG | $750,000 |
Mallinckrodt LLC | Mallinckrodt | False Claims Act and related | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,500,000 |
Merck | Merck | False Claims Act and related | 2008 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $290,000,000 |
Merck & Co., Inc. | Merck | False Claims Act and related | 2011 | MA-AG | $24,000,000 |
Merck and Company, Inc. | Merck | False Claims Act and related | 2011 | WI-AG | $4,250,000 |
Merck Sharp & Dohme Corp | Merck | False Claims Act and related | 2010 | HI-AG | $28,000,000 |
Merck Sharp & Dohme Corp. | Merck | False Claims Act and related | 2011 | ID-AG | $1,600,000 |
Merck Sharp & Dohme Corp. | Merck | False Claims Act and related | 2012 | KY-AG | $6,000,000 |
Mylan Inc. | Viatris | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $465,000,000 |
Mylan Inc. | Viatris | False Claims Act and related | 2010 | MA-AG | $2,600,000 |
Mylan Laboratories Inc. | Viatris | False Claims Act and related | 2010 | TX-AG | $23,000,000 |
Mylan Laboratories Inc. And Mylan Pharmaceuticals Inc. | Viatris | False Claims Act and related | 2012 | ID-AG | $625,000 |
Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc. | Viatris | False Claims Act and related | 2011 | KY-AG | $6,500,000 |
Mylan Pharmaceuticals, Inc. | Viatris | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $118,000,000 |
Novartis | Novartis | False Claims Act and related | 2013 | LA-AG | $7,000,000 |
Novartis Pharmaceuticals Corp. | Novartis | False Claims Act and related | 2013 | ID-AG | $750,000 |
Novartis Pharmaceuticals Corp. | Novartis | False Claims Act and related | 2012 | KY-AG | $2,750,000 |
Novartis Pharmaceuticals Corporation | Novartis | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Novo Nordisk Inc. | Novo Holdings A/S | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,320,963 |
Ortho-McNeil Pharmaceutical, Inc. | Johnson & Johnson | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,400,000 |
OSI Pharmaceuticals LLC | Astellas Pharma | False Claims Act and related | 2016 | DOJ_CIVIL | $33,500,000 |
OSI Pharmaceuticals LLC | Astellas Pharma | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,200,000 |
Par Pharmaceutical | Endo International | False Claims Act and related | 2013 | LA-AG | $6,000,000 |
Par Pharmaceutical Co. | Endo International | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
Par Pharmaceutical Cos., Inc. | Endo International | False Claims Act and related | 2011 | ID-AG | $1,700,000 |
Par Pharmaceutical Inc. | Endo International | False Claims Act and related | 2011 | KY-AG | $4,500,000 |
Par Pharmaceutical, Inc. | Endo International | False Claims Act and related | 2010 | MA-AG | $500,000 |
Par Pharmaceuticals, Inc. | Endo International | False Claims Act and related | 2011 | MULTI-AG | $154,000,000 |
Pernix Therapeutics | Currax Pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $800,000 |
Perrigo | Perrigo | False Claims Act and related | 2013 | LA-AG | $2,000,000 |
Pfizer Inc. | Pfizer | False Claims Act and related | 2002 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $21,084,700 |
Pfizer Inc. | Pfizer | False Claims Act and related | 2011 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,621,154 |
Pfizer Inc. | Pfizer | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
Pfizer Inc. and Pharmacia Corp. | Pfizer | False Claims Act and related | 2012 | ID-AG | $2,900,000 |
Pfizer, Inc. and Pharmacia Corporation | Pfizer | False Claims Act and related | 2010 | HI-AG | $8,200,000 |
Pharmacia Corp. | Pfizer | False Claims Act and related | 2009 | OH-AG | $400,000 |
Pharmacia Corporation | Pfizer | False Claims Act and related | 2011 | NY-AG | $2,500,000 |
Pharmacia Corporation | Pfizer | False Claims Act and related | 2013 | WI-AG | $29,453,247 |
Purdue Frederick Co. | Purdue Pharma | False Claims Act and related | 2008 | TX-AG | $1,600,000 |
Purdue Frederick Company Inc. | Purdue Pharma | False Claims Act and related | 2007 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $160,000,000 |
Purepac Pharmaceutical Co. | Pfizer | False Claims Act and related | 2010 | ID-AG | $600,000 |
Purepac Pharmaceutical Co., n/k/a Actavis Elizabeth, LLC | Pfizer | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
Ranbaxy | Sun Pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $5,000,000 |
Ranbaxy Pharmaceuticals, Inc. et al. | Sun Pharmaceuticals | False Claims Act and related | 2014 | TX-AG | $17,875,000 |
Roxane Laboratories Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2009 | OH-AG | $2,400,000 |
Roxane Laboratories, Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2009 | FL-AG | $8,500,000 |
Roxane Laboratories, Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
Roxane, Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2010 | MO-AG | $3,100,000 |
Roxanne Laboratories and Boehringer Ingelheim | Hikma Pharmaceuticals | False Claims Act and related | 2008 | AL-AG | $9,500,000 |
Sandoz | Sandoz Group | False Claims Act and related | 2009 | KY-AG | $16,000,000 |
Sandoz | Sandoz Group | False Claims Act and related | 2013 | LA-AG | $13,100,000 |
Sandoz Inc. | Sandoz Group | False Claims Act and related | 2010 | ID-AG | $1,650,000 |
Sandoz, Inc. | Sandoz Group | False Claims Act and related | 2011 | MS-AG | $30,110,618 |
Sanofi-Aventis U.S. LLC | Sanofi | False Claims Act and related | 2012 | ID-AG | $828,500 |
Schering-Plough | Merck | False Claims Act and related | 2012 | LA-AG | $5,000,000 |
Schering-Plough | Merck | False Claims Act and related | 2008 | MO-AG | $31,000,000 |
Schering-Plough Corp. | Merck | False Claims Act and related | 2004 | TX-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $27,000,000 |
Schwarz Pharma Inc. | UCB | False Claims Act and related | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $9,756,164 |
Shering-Plough/Warrick Companies | Merck | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Shire | Takeda Pharmaceutical | False Claims Act and related | 2013 | LA-AG | $4,000,000 |
Shire Pharmaceuticals LLC | Takeda Pharmaceutical | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,104,000 |
SmithKline Beecham Corp. | GlaxoSmithKline | False Claims Act and related | 2007 | TX-AG | $1,400,000 |
Takeda Pharmaceuticals | Takeda Pharmaceutical | False Claims Act and related | 2008 | AL-AG | $2,000,000 |
Takeda/Tap Pharmaceuticals | Takeda Pharmaceutical | False Claims Act and related | 2013 | LA-AG | $3,750,000 |
TAP Pharmaceutical Products | Takeda Pharmaceutical | False Claims Act and related | 2011 | PA-AG | $5,240,797 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | False Claims Act and related | 2001 | AR-AG | $525,780 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | False Claims Act and related | 2001 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $25,516,440 |
Taro Pharmaceutical Industries | Sun Pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $5,000,000 |
Taro Pharmaceuticals USA, Inc. | Sun Pharmaceuticals | False Claims Act and related | 2014 | TX-AG | $8,750,000 |
Teva Pharmaceutical USA, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2009 | MA-AG | $7,000,000 |
TEVA Pharmaceuticals USA | Teva Pharmaceutical Industries | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Teva Pharmaceuticals USA Inc., IVAX Corporation, IVAX Pharmaceuticals Inc., Sicor Inc., Barr Laboratories Inc. and Duramed Pharmaceuticals Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | KY-AG | $10,000,000 |
Teva Pharmaceuticals USA, Inc. et al. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | HI-AG | $6,500,000 |
Teva Pharmaceuticals USA, Inc., Ivax Corp., Ivax Pharmaceuticals, Inc., and Barr Laboratories, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | ID-AG | $1,900,000 |
Teva Pharmaceuticals Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | MULTI-AG | $169,000,000 |
UCB | UCB | False Claims Act and related | 2013 | LA-AG | $3,350,000 |
Warner Chilcott PLC | AbbVie | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,600,000 |
Warrick Pharmaceuticals Corp. and Schering-Plough Corp. | Merck | False Claims Act and related | 2011 | ID-AG | $750,000 |
Warrick Pharmaceuticals Inc. | Merck | False Claims Act and related | 2009 | OH-AG | $4,300,000 |
Watson Pharmaceuticals | Teva Pharmaceutical Industries | False Claims Act and related | 2011 | MULTI-AG | $70,000,000 |
Watson Pharmaceuticals Inc. and Watson Pharma Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2012 | ID-AG | $1,700,000 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | MA-AG | $2,400,000 |
Watson, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2018 | MS-AG | $33,408,547 |
Watson/Schein Pharmaceuticals Inc. | AbbVie | False Claims Act and related | 2011 | TX-AG | $11,300,000 |
Wyeth Pharmaceuticals, Inc. | Pfizer | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $371,351,180 |